Fulcrum Pharma
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fulcrum Pharma - overview
Established
1999
Location
Hemel Hempstead, -, UK
Primary Industry
Pharmaceuticals
About
Fulcrum Pharma specializes in pharmaceutical development services, providing comprehensive support for biopharmaceutical products from concept to market approval, including clinical trials and regulatory compliance. Fulcrum Pharma, founded in 1999 in Hemel Hempstead, UK, offers pharmaceutical development services. The company was part of the merger that created Aptiv Solutions in February 2011. It has secured a total of USD 143.
50 mn across various funding rounds, with the most recent being a TRADE SALE on March 31, 2014, involving investors like ICON Plc. The company has executed 2 deals to date. Fulcrum Pharma offers comprehensive solutions in pharmaceutical development, including clinical development, regulatory compliance, and pharmacovigilance. Their services cover Chemistry, Manufacturing, and Controls (CMC) optimization, along with clinical trial management from Phase I to post-marketing studies, catering to clients in Europe, the United States, and Japan.
In the most recent year, Fulcrum Pharma reported a revenue of USD 0 mn and an EBITDA of USD -2,079,041. 20 for the year 2010. Fulcrum Pharma aims to leverage recent funding from the TRADE SALE to enhance its service offerings and expand into new markets. The company is focusing on launching new products by the end of the next fiscal year, with plans to enter markets in Asia and South America by 2015.
They are utilizing their expertise to better serve clients and strengthen their market position.
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Pharmaceuticals
Website
www.fulcrumpharma.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Fulcrum Pharma - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Fulcrum Pharma | - | ||||||||
| Public to Private | Completed | Fulcrum Pharma | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.